Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer

Summary

This phase I trial studies the side effects and best dose of gemcitabine hydrochloride in treating patients with locally advanced pancreatic cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

Timeline

Start

2013-04

Primary completion

2015-10-30

Completion

2015-10-30

Drugs

Indications